A synthetic investigational peptide studied as a triple receptor agonist targeting GLP-1R, GIPR, and GCGR. It is widely used in research involving multi-receptor pharmacology, endocrine signaling, peptide engineering, and receptor interaction studies.
Not for human consumption
Retatrutide is a synthetic 39-amino acid peptide with a molecular weight of approximately 4,733.4 Da. It is an engineered peptide analogue incorporating structural modifications that enhance stability while preserving receptor affinity. Designed as a triple receptor agonist, retatrutide represents one of the most structurally advanced investigational peptides currently described in the scientific literature.
Retatrutide has been extensively characterized in published research for its interaction with the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR). It serves as a widely recognized research tool for investigating multi-receptor pharmacology, peptide engineering, endocrine signaling, receptor binding kinetics, and structure-activity relationships.
You must be at least 21 years old to access The Research Peptides.
All products are sold strictly for in-vitro laboratory research use only.